Work for Onconova Therapeutics, Inc.?

Claim Your Profile

Onconova Therapeutics, Inc. Logo Image

Onconova Therapeutics, Inc.

About Onconova Therapeutics, Inc.

11-50 Employees
Based in Newtown, Pennsylvania

Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol